Rights and permissions
About this article
Cite this article
Orlistat worthwhile for obesity in patients with type 2 DM. Pharmacoecon. Outcomes News 352, 7 (2002). https://doi.org/10.1007/BF03278761
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03278761